Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - ascorbic acid; vitamin a; biotin; lecithin; folic acid; magnesium sulfate; dibasic calcium phosphate, anhydr.; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine; thiamine hydrochloride/vit b1; vit e,dl-alpha tocopheryl acetate; vitamin d 3; nicotinamide; zinc sulfate monohydrate; sodium selenite anhydrous; panax ginseng; iron (ii) sulfate, dried; copper (ii) sulfate, anhydrous; manganese (ii) sulphate, monohydrate -

United States - English - NLM (National Library of Medicine)

spirit pharmaceuticals,llc - ferrous sulfate, dried (unii: rib00980vw) (iron - unii:e1uol152h7) - ferrous sulfate, dried 325 mg - iron supplement therapy ferrous sulphate is an iron supplement for iron deficiency and iron deficiency anemia when the need for such therapy has been determined by a physician.

United States - English - NLM (National Library of Medicine)

spirit pharmaceuticals,llc - ferrous sulfate, dried (unii: rib00980vw) (iron - unii:e1uol152h7) - iron supplement therapy ferrous sulphate is an iron supplement for iron deficiency and iron deficiency anemia when the need for such therapy has been determined by a physician.

Ireland - English - HPRA (Health Products Regulatory Authority)

foran healthcare limited, - magnesium sulfate dried - cutaneous paste - 38.5 percent weight/weight - other dermatologicals; magnesium sulfate

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - tranylcypromine sulfate (unii: 7zat6es870) (tranylcypromine - unii:3e3v44j4z9) - tranylcypromine 10 mg - tranylcypromine sulfate is indicated for the treatment of major depressive disorder (mdd) in adult patients who have not responded adequately to other antidepressants. tranylcypromine sulfate is not indicated for the initial treatment of mdd due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [ see contraindications (4), warnings and precautions (5), and drug interactions (7)] . concomitant use of tranylcypromine sulfate or use in rapid succession with the products in table 1 is contraindicated. such use may cause severe or life-threatening reactions such as hypertensive crises or serotonin syndrome [see drug interactions (7.1)]. medication-free periods between administration of tranylcypromine sulfate and contraindicated agents are recommended [ see dosage and administration (2.2) and drug interactions (7.1) ]. table 1: pr

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - tranylcypromine sulfate (unii: 7zat6es870) (tranylcypromine - unii:3e3v44j4z9) - tranylcypromine 10 mg - tranylcypromine sulfate is indicated for the treatment of major depressive disorder (mdd) in adult patients who have not responded adequately to other antidepressants. tranylcypromine sulfate is not indicated for the initial treatment of mdd due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [see contraindications (4), warnings and precautions (5), and drug interactions (7)] . concomitant use of tranylcypromine sulfate or use in rapid succession with the products in table 1 is contraindicated. such use may cause severe or life-threatening reactions such as hypertensive crises or serotonin syndrome [see drug interactions (7.1)]. medication-free periods between administration of tranylcypromine sulfate and contraindicated agents are recommended [ see dosage and administration (2.2) and drug interactions (7.1) ]. table 1: products contraindicated with the use of tranylcypromine sulfate - other monoamine oxidase inhibitors (maois) - selective se

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - ferrous sulfate dried - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - ferrous sulfate dried - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - ferrous sulfate dried - oral tablet - 200mg

Australia - English - Department of Health (Therapeutic Goods Administration)

ferromedica holdings pty ltd - ferrous sulfate, quantity: 325 mg; ascorbic acid, quantity: 500 mg - tablet, modified release - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000; lecithin; iron oxide red; macrogol 4000 - for the prevention and treatment of iron deficiency anaemia; iron and vitamin c supplementation which may help relieve fatigue, where dietary intake of both nutrients is inadequate.